Robert K. Hills
- Hematology top 0.02%
- Acute Myeloid Leukemia Research 157
- Chronic Myeloid Leukemia Treatments 36
- Multiple Myeloma Research and Treatments 32
- Genetics top 0.1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 22
- Chronic Lymphocytic Leukemia Research 20
-
- Acute Lymphoblastic Leukemia research 72
- Oncology top 1%
- Molecular Biology top 1%
- Retinoids in leukemia and cellular processes 34
- Histone Deacetylase Inhibitors Research 19
- Co-authors
- Alan K. BurnettKeith WheatleyDavid GrimwadeNigel H. RussellRosemary E. GaleAnthony H. GoldstoneDavid C. LinchDonald Milligan
- Journals
- Blood (98 papers)British Journal of Haematology (25 papers)Journal of Clinical Oncology (21 papers)
- Partner nations
- United KingdomUnited StatesDenmark
In The Last Decade
Robert K. Hills
243 papers receiving 14.4k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Hematology 9.7k
- Genetics 2.9k
- Public Health, Environmental and Occupational Health 3.9k
- Oncology 2.2k
- Molecular Biology 5.4k
Countries citing papers authored by Robert K. Hills
This map shows the geographic impact of Robert K. Hills's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert K. Hills with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert K. Hills more than expected).
Fields of papers citing papers by Robert K. Hills
This network shows the impact of papers produced by Robert K. Hills. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert K. Hills. The network helps show where Robert K. Hills may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert K. Hills, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2021 | 2 | |
| 3 | 2021 | 7 | |
| 4 | 2020 | 19 | |
| 5 | 2019 | 39 | |
| 6 | 2017 | 119 | |
| 7 | 2016 | 17 | |
| 8 | Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trialbreakdown → | 2015 | 346 |
| 9 | 2015 | 34 | |
| 10 | Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trialsbreakdown → | 2014 | 479 |
| 11 | 2013 | 289 | |
| 12 | 2013 | 50 | |
| 13 | Refinement of cytogenetic classification in acute myeloid leukaemia: Determination of prognostic significance of rarer recurring chromosomal abnormalities amongst 5,876 younger adult patients treated in the UK Medical Research Council trials | 2010 | 29 |
| 14 | 2009 | 42 | |
| 15 | THE PROGNOSTIC ROLE OF C-FLIP IN AML | 2009 | 1 |
| 16 | REFINEMENT OF CYTOGENETIC CLASSIFICATION IN AML: DETERMINATION OF PROGNOSTIC SIGNIFICANCE OF RARE RECURRING CHROMOSOMAL ABNORMALITIES AMONGST 5635 YOUNGER ADULTS TREATED IN THE UK MRC TRIALS | 2009 | 5 |
| 17 | PROSPER: A uniquely flexible randomised controlled trial in rectal prolapse repair | 2003 | 2 |
| 18 | Attempts to modulate chemoresistance in older patients with AML using PSC-833 - Results of the LRF AML14 trial | 2003 | 4 |
| 19 | The relationship between FLT3 mutation status: biological characteristics and outcome in patients with acute promyelocytic leukaemia. | 2003 | 3 |
| 20 | 1994 | 18 |
About Robert K. Hills
Robert K. Hills is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 246 papers that have together received 14.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (157 papers), Acute Lymphoblastic Leukemia research (72 papers), Chronic Myeloid Leukemia Treatments (36 papers), Retinoids in leukemia and cellular processes (34 papers), Multiple Myeloma Research and Treatments (32 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Histone Deacetylase Inhibitors Research (19 papers). The work is most often cited by research in Hematology (9.7k citations), Genetics (2.9k citations) and Public Health, Environmental and Occupational Health (3.9k citations). Robert K. Hills has collaborated with scholars based in United Kingdom, United States and Denmark. Frequent co-authors include Alan K. Burnett, Keith Wheatley, David Grimwade, Nigel H. Russell, Rosemary E. Gale, Anthony H. Goldstone, David C. Linch, Donald Milligan, Anthony V. Moorman and Alan K. Burnett. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Clinical Oncology, Leukemia and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.